View in EDS HTML Full Text PDF Full Text

Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.

Saved in:
Bibliographic Details
Title: Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Authors: Martín M; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rodríguez-Lescure Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain., Andrés R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Servitja S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain., Antón A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain., Ruiz-Borrego M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Bermejo B; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain., Guerrero Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Ramos M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain., Santaballa A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain., Muñoz M; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Cruz J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Lopez-Tarruella S; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Chacón JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Toledo, Toledo, Spain., Álvarez I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastian, Spain., Martínez P; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain., Miralles JJ; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Polonio Ó; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Jara C; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Aguiar-Bujanda D; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Sep; Vol. 201 (2), pp. 151-159. Date of Electronic Publication: 2023 Jun 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37338729
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martín+M%22">Martín M</searchLink>; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. mmartin@geicam.org.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain. mmartin@geicam.org.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. mmartin@geicam.org.<br /><searchLink fieldCode="AU" term="%22Carrasco+E%22">Carrasco E</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Lescure+Á%22">Rodríguez-Lescure Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital General Universitario de Elche, Elche, Spain.<br /><searchLink fieldCode="AU" term="%22Andrés+R%22">Andrés R</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Servitja+S%22">Servitja S</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Antón+A%22">Antón A</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Universitario Miguel Servet, Universidad de Zaragoza, Instituto Investigación Sanitaria Aragón (IISA), Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Ruiz-Borrego+M%22">Ruiz-Borrego M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Bermejo+B%22">Bermejo B</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA. Universidad de Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Guerrero+Á%22">Guerrero Á</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Ramos+M%22">Ramos M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro Oncológico de Galicia, A Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Santaballa+A%22">Santaballa A</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz+M%22">Muñoz M</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Medical Oncology and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cruz+J%22">Cruz J</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.<br /><searchLink fieldCode="AU" term="%22Lopez-Tarruella+S%22">Lopez-Tarruella S</searchLink>; Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Chacón+JI%22">Chacón JI</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Toledo, Toledo, Spain.<br /><searchLink fieldCode="AU" term="%22Álvarez+I%22">Álvarez I</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital de Donostia, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez+P%22">Martínez P</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Basurto, Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22Miralles+JJ%22">Miralles JJ</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Polonio+Ó%22">Polonio Ó</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Jara+C%22">Jara C</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.<br /><searchLink fieldCode="AU" term="%22Aguiar-Bujanda+D%22">Aguiar-Bujanda D</searchLink>; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2023 Sep; Vol. 201 (2), pp. 151-159. <i>Date of Electronic Publication: </i>2023 Jun 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37338729
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-023-07002-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 151
    Titles:
      – TitleFull: Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martín M
      – PersonEntity:
          Name:
            NameFull: Carrasco E
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Lescure Á
      – PersonEntity:
          Name:
            NameFull: Andrés R
      – PersonEntity:
          Name:
            NameFull: Servitja S
      – PersonEntity:
          Name:
            NameFull: Antón A
      – PersonEntity:
          Name:
            NameFull: Ruiz-Borrego M
      – PersonEntity:
          Name:
            NameFull: Bermejo B
      – PersonEntity:
          Name:
            NameFull: Guerrero Á
      – PersonEntity:
          Name:
            NameFull: Ramos M
      – PersonEntity:
          Name:
            NameFull: Santaballa A
      – PersonEntity:
          Name:
            NameFull: Muñoz M
      – PersonEntity:
          Name:
            NameFull: Cruz J
      – PersonEntity:
          Name:
            NameFull: Lopez-Tarruella S
      – PersonEntity:
          Name:
            NameFull: Chacón JI
      – PersonEntity:
          Name:
            NameFull: Álvarez I
      – PersonEntity:
          Name:
            NameFull: Martínez P
      – PersonEntity:
          Name:
            NameFull: Miralles JJ
      – PersonEntity:
          Name:
            NameFull: Polonio Ó
      – PersonEntity:
          Name:
            NameFull: Jara C
      – PersonEntity:
          Name:
            NameFull: Aguiar-Bujanda D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 201
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1